ANF-Rho in the Treatment of Chronic Neutropenia
NCT02533362
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Conditions
Neutropenia, Severe Chronic
Interventions
DRUG:
ANF-Rho
Sponsor
Prolong Pharmaceuticals